vaccine Archives
Hope for an RSV vaccine
Feb. 23, 2018—Newly discovered features in an RSV protein may be useful for rational structure-based vaccine design.
Schaffner receives UpShot Award in vaccine communication
Jun. 15, 2017—The National Vaccine Program Office in the U.S. Department of Health and Human Services has selected William Schaffner, M.D., to receive its 2017 NVPO UpShot Award in Vaccine Communication.
Flu vaccine response in older adults
Jan. 25, 2017—High dose flu vaccine boosts the immune response in older adults by increasing activation of certain immune cells.
Improving vaccine formulations
Jan. 20, 2017—The compound MPLA is an attractive vaccine component, designed to elicit a robust immune response.
High-dose flu vaccine more effective in elderly, Vanderbilt-led study shows
Aug. 13, 2014—High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.
Respiratory virus vaccine candidate
May. 27, 2014—Virus-like particles containing a protein from human metapneumovirus are a promising vaccine candidate for this respiratory virus.
Cutting-edge research to be showcased in May
May. 1, 2014—Potentially “game-changing” research at Vanderbilt University on infectious diseases, population health and health policy will be showcased during two interactive presentations May 15 and May 22. A segment of the Flexner Discovery Lecture Series, the new “Vanderbilt Cutting-edge Discovery” discussions are highlights of recent presentations to the Vanderbilt Biomedical Science Advisory Board, a group of...
Vanderbilt Vaccine Center joins global task force to address urgent viral threat
Apr. 7, 2014—World Health Day 2014 Shines Spotlight on Mosquito-borne Viral Diseases Chikungunya virus, a vector-borne disease that is quickly spread by mosquitoes and causes victims to suffer severe fever and pain, has reached the Caribbean and South America—and is predicted to soon cause outbreaks in the United States. For many years the virus has remained primarily...
HIV’s impact on B cells
Jan. 15, 2014—Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.
Flulapalooza vaccination event set for Sept. 25
Aug. 15, 2013—Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination event that two years ago more than doubled the current world record for the total number of vaccinations given in an eight-hour period.
Study lays groundwork for rational T cell vaccine design
May. 30, 2013—Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response.
UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
Nov. 12, 2012—Collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations in the coronavirus responsible for deadly severe acute respiratory syndrome (SARS) cripples the virus’s ability to cause disease in animals.
